Liver disease and dyslipidemia as a manifestation of lysosomal acid lipase deficiency (LAL-D). Clinical and diagnostic aspects, and a new treatment. An update

Lysosomal acid lipase deficiency (LAL-D) is still a little recognized genetic disease with significant morbidity and mortality in children and adults. This document provides guidance on when to suspect LAL-D and how to diagnose it. It is recommended to add lysosomal acid lipase deficiency to the lis...

Descripción completa

Detalles Bibliográficos
Autores principales: Bay, Luisa, Cañero Velasco, Cristina, Ciocca, Mirta, Cotti, Andrea, Cuarterolo, Miriam, Fainboim, Alejandro, Fassio, Eduardo, Galoppo, Marcela, Piñero, Federico, Rozenfeld, Paula
Formato: Articulo Revision
Lenguaje:Inglés
Publicado: 2017
Materias:
Acceso en línea:http://sedici.unlp.edu.ar/handle/10915/87678
Aporte de:
id I19-R120-10915-87678
record_format dspace
institution Universidad Nacional de La Plata
institution_str I-19
repository_str R-120
collection SEDICI (UNLP)
language Inglés
topic Ciencias Médicas
Ciencias Exactas
Cirrhosis
Dyslipidemias
Lysosomal acid lipase deficiency
Non-alcoholic fatty liver disease
Wolman disease
spellingShingle Ciencias Médicas
Ciencias Exactas
Cirrhosis
Dyslipidemias
Lysosomal acid lipase deficiency
Non-alcoholic fatty liver disease
Wolman disease
Bay, Luisa
Cañero Velasco, Cristina
Ciocca, Mirta
Cotti, Andrea
Cuarterolo, Miriam
Fainboim, Alejandro
Fassio, Eduardo
Galoppo, Marcela
Piñero, Federico
Rozenfeld, Paula
Liver disease and dyslipidemia as a manifestation of lysosomal acid lipase deficiency (LAL-D). Clinical and diagnostic aspects, and a new treatment. An update
topic_facet Ciencias Médicas
Ciencias Exactas
Cirrhosis
Dyslipidemias
Lysosomal acid lipase deficiency
Non-alcoholic fatty liver disease
Wolman disease
description Lysosomal acid lipase deficiency (LAL-D) is still a little recognized genetic disease with significant morbidity and mortality in children and adults. This document provides guidance on when to suspect LAL-D and how to diagnose it. It is recommended to add lysosomal acid lipase deficiency to the list of differential diagnoses of sepsis, oncological diseases, storage diseases, persistent diarrhea, chronic malnutrition, and hemophagocytic lymphohistiocytosis. It should also be considered in young patients with dyslipidemia and atherosclerosis as well as diseases associated with fatty liver and/or hepatomegaly. LAL-D should be suspected in patients with hepatomegaly, hyperlipidemia and/or elevated transaminases found during routine checks or testing for other conditions, and in patients with cryptogenic cirrhosis. At present, there is the option of a specific enzyme replacement treatment.
format Articulo
Revision
author Bay, Luisa
Cañero Velasco, Cristina
Ciocca, Mirta
Cotti, Andrea
Cuarterolo, Miriam
Fainboim, Alejandro
Fassio, Eduardo
Galoppo, Marcela
Piñero, Federico
Rozenfeld, Paula
author_facet Bay, Luisa
Cañero Velasco, Cristina
Ciocca, Mirta
Cotti, Andrea
Cuarterolo, Miriam
Fainboim, Alejandro
Fassio, Eduardo
Galoppo, Marcela
Piñero, Federico
Rozenfeld, Paula
author_sort Bay, Luisa
title Liver disease and dyslipidemia as a manifestation of lysosomal acid lipase deficiency (LAL-D). Clinical and diagnostic aspects, and a new treatment. An update
title_short Liver disease and dyslipidemia as a manifestation of lysosomal acid lipase deficiency (LAL-D). Clinical and diagnostic aspects, and a new treatment. An update
title_full Liver disease and dyslipidemia as a manifestation of lysosomal acid lipase deficiency (LAL-D). Clinical and diagnostic aspects, and a new treatment. An update
title_fullStr Liver disease and dyslipidemia as a manifestation of lysosomal acid lipase deficiency (LAL-D). Clinical and diagnostic aspects, and a new treatment. An update
title_full_unstemmed Liver disease and dyslipidemia as a manifestation of lysosomal acid lipase deficiency (LAL-D). Clinical and diagnostic aspects, and a new treatment. An update
title_sort liver disease and dyslipidemia as a manifestation of lysosomal acid lipase deficiency (lal-d). clinical and diagnostic aspects, and a new treatment. an update
publishDate 2017
url http://sedici.unlp.edu.ar/handle/10915/87678
work_keys_str_mv AT bayluisa liverdiseaseanddyslipidemiaasamanifestationoflysosomalacidlipasedeficiencylaldclinicalanddiagnosticaspectsandanewtreatmentanupdate
AT canerovelascocristina liverdiseaseanddyslipidemiaasamanifestationoflysosomalacidlipasedeficiencylaldclinicalanddiagnosticaspectsandanewtreatmentanupdate
AT cioccamirta liverdiseaseanddyslipidemiaasamanifestationoflysosomalacidlipasedeficiencylaldclinicalanddiagnosticaspectsandanewtreatmentanupdate
AT cottiandrea liverdiseaseanddyslipidemiaasamanifestationoflysosomalacidlipasedeficiencylaldclinicalanddiagnosticaspectsandanewtreatmentanupdate
AT cuarterolomiriam liverdiseaseanddyslipidemiaasamanifestationoflysosomalacidlipasedeficiencylaldclinicalanddiagnosticaspectsandanewtreatmentanupdate
AT fainboimalejandro liverdiseaseanddyslipidemiaasamanifestationoflysosomalacidlipasedeficiencylaldclinicalanddiagnosticaspectsandanewtreatmentanupdate
AT fassioeduardo liverdiseaseanddyslipidemiaasamanifestationoflysosomalacidlipasedeficiencylaldclinicalanddiagnosticaspectsandanewtreatmentanupdate
AT galoppomarcela liverdiseaseanddyslipidemiaasamanifestationoflysosomalacidlipasedeficiencylaldclinicalanddiagnosticaspectsandanewtreatmentanupdate
AT pinerofederico liverdiseaseanddyslipidemiaasamanifestationoflysosomalacidlipasedeficiencylaldclinicalanddiagnosticaspectsandanewtreatmentanupdate
AT rozenfeldpaula liverdiseaseanddyslipidemiaasamanifestationoflysosomalacidlipasedeficiencylaldclinicalanddiagnosticaspectsandanewtreatmentanupdate
bdutipo_str Repositorios
_version_ 1764820489282256900